Clinuvel Pharmaceuticals Limited

Clinuvel Pharmaceuticals Limitedverified

CLVLF

Price:

$7.54

Market Cap:

$618.03M

Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally. Its lead drug candidate is SCENESSE, a systemic photoprotective drug for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria (EPP). The company's pipeline products include CUV9900, an alpha-melanocyte stimulating hormone analogue; Parvysmelanotide (VLRX001), which provoke increased and prolonged cellular activity; and PRÉNUMBRA, a liquid injectable formulation of afamelanotide. Clinuvel Pharmaceuticals L...[Read more]

Industry

Biotechnology

IPO Date

2009-02-13

Stock Exchange

OTC

Ticker

CLVLF

The PE Ratio as of December 2025 (TTM) for Clinuvel Pharmaceuticals Limited (CLVLF) is 16.04

According to Clinuvel Pharmaceuticals Limited’s latest financial reports and current stock price. The company's current PE Ratio is 16.04. This represents a change of 49.94% compared to the average of 10.70 of the last 4 quarters.

Clinuvel Pharmaceuticals Limited (CLVLF) Historical PE Ratio (quarterly & annually)

How has CLVLF PE Ratio performed in the past?

The mean historical PE Ratio of Clinuvel Pharmaceuticals Limited over the last ten years is 34.86. The current 16.04 PE Ratio has changed 4.50% with respect to the historical average. Over the past ten years (40 quarters), CLVLF's PE Ratio was at its highest in in the June 2016 quarter at 395.03. The PE Ratio was at its lowest in in the June 2007 quarter at -12.44.

Quarterly (TTM)
Annual

Average

34.86

Median

37.45

Minimum

-62.68

Maximum

87.69

Clinuvel Pharmaceuticals Limited (CLVLF) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Clinuvel Pharmaceuticals Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 429.10%

Maximum Annual PE Ratio = 87.69

Minimum Annual Increase = -173.93%

Minimum Annual PE Ratio = -62.68

Quarterly (TTM)
Annual
YearPE RatioChange
202514.37-34.32%
202421.88-24.21%
202328.87-17.86%
202235.14-42.71%
202161.34-19.18%
202075.90-13.45%
201987.69120.62%
201839.75-14.22%
201746.34-173.93%
2016-62.68429.10%

Clinuvel Pharmaceuticals Limited (CLVLF) Average PE Ratio

How has CLVLF PE Ratio performed in the past?

The current PE Ratio of Clinuvel Pharmaceuticals Limited (CLVLF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

21.70

5-year avg

32.32

10-year avg

34.86

Clinuvel Pharmaceuticals Limited (CLVLF) PE Ratio vs. Peers

How is CLVLF’s PE Ratio compared to its peers?

Clinuvel Pharmaceuticals Limited’s PE Ratio is less than Frontage Holdings Corporation (72.18), greater than Immutep Limited (-6.17), greater than Northwest Biotherapeutics, Inc. (-3.88), greater than CytoDyn Inc. (-19.36), greater than PureTech Health plc (7.49), greater than Cellectis S.A. (-8.03), greater than Healios K.K. (-7.51), greater than hVIVO plc (3.18), greater than Euroapi S.A. (-2.30), greater than Hansa Biopharma AB (publ) (-4.42),

Build a custom stock screener for Clinuvel Pharmaceuticals Limited (CLVLF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Clinuvel Pharmaceuticals Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Clinuvel Pharmaceuticals Limited (CLVLF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Clinuvel Pharmaceuticals Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Clinuvel Pharmaceuticals Limited's PE Ratio?

How is the PE Ratio calculated for Clinuvel Pharmaceuticals Limited (CLVLF)?

What is the highest PE Ratio for Clinuvel Pharmaceuticals Limited (CLVLF)?

What is the 3-year average PE Ratio for Clinuvel Pharmaceuticals Limited (CLVLF)?

What is the 5-year average PE Ratio for Clinuvel Pharmaceuticals Limited (CLVLF)?

How does the current PE Ratio for Clinuvel Pharmaceuticals Limited (CLVLF) compare to its historical average?